In this program, we will discover how recent guidelines updates impact antithrombotic treatment options for high bleeding risk (HBR) patients. A detailed analysis of a complex patient case will uncover its practical implications.
5.00 pm
|
Introduction & patient case presentation
|
5.05 pm |
Analyse a complex patient case to understand guideline implications on your daily practice
|
5.45 pm |
Panel Discussion & Take Home message
|